Syndax Pharmaceuticals Inc. (SNDX)
NASDAQ · Healthcare
Syndax Pharmaceuticals Inc. Shareholder Equity 2015–2025
Syndax Pharmaceuticals Inc. annual/quarterly shareholder equity history from 2015 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Syndax Pharmaceuticals Inc. shareholder equity for the quarter ending December 31, 2025 were 64.6M, a 77.57% decrease year-over-year.
- Syndax Pharmaceuticals Inc. shareholder equity for 2025 were 64.6M, a 77.57% decrease from 2024.
- Syndax Pharmaceuticals Inc. shareholder equity for 2024 were 288.1M, a 48.01% decrease from 2023.
- Syndax Pharmaceuticals Inc. shareholder equity for 2023 were 554.2M, a 18.56% increase from 2022.
- Syndax Pharmaceuticals Inc. shareholder equity for 2022 were 467.4M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Syndax Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $65 |
| 2024 | $288 |
| 2023 | $554 |
| 2022 | $467 |
| 2021 | $408 |
| 2020 | $252 |
| 2019 | $32 |
| 2018 | $53 |
| 2017 | $104 |
| 2016 | $84 |
| 2015 | $-252 |
| Syndax Pharmaceuticals Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $65 |
| 2024-12-31 | $288 |
| 2023-12-31 | $554 |
| 2022-12-31 | $467 |
| 2021-12-31 | $408 |
| 2020-12-31 | $252 |
| 2019-12-31 | $32 |
| 2018-12-31 | $53 |
| 2017-12-31 | $104 |
| 2016-12-31 | $84 |
| 2015-12-31 | $-252 |
Syndax Pharmaceuticals Inc. Shareholder Equity — FAQ
Syndax Pharmaceuticals Inc. (SNDX) shareholder equity over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SNDX's shareholder equity history?
The chart and table above show Syndax Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.